CEBPA and neoplasm: In line with the prognostic results, the multivariate analysis of tumor response to chemotherapy revealed associations between the presence of the CEBPA c.690 G>T SNP and almost 7-fold decrease of sensitivity to the PC treatment (OR 0.144, 95% CI 0.027-0.778, p=0.024) (Figure 1C).